Computational neural network analysis of the affinity of lobeline and tetrabenazine analogs for the vesicular monoamine transporter-2

被引:23
|
作者
Zheng, Fang [1 ]
Zheng, Guangrong [1 ]
Deaciuc, A. Gabriela [1 ]
Zhan, Chang-Guo [1 ]
Dwoskin, Linda P. [1 ]
Crooks, Peter A. [1 ]
机构
[1] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40536 USA
关键词
lobeline analog; QSAR; partial least squares; artificial neural network; VMAT2;
D O I
10.1016/j.bmc.2007.02.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Back-propagation artificial neural networks (ANNs) were trained on a dataset of 104 VMAT2 ligands with experimentally measured log(l/K-i) values. A set of related descriptors, including topological, geometrical, GETAWAY, aromaticity, and WHIM descriptors, was selected to build nonlinear quantitative structure-activity relationships. A partial least squares (PLS) regression model was also developed for comparison. The nonlinearity of the relationship between molecular descriptors and VMAT2 ligand activity was demonstrated. The obtained neural network model outperformed the PLS model in both the fitting and predictive ability. ANN analysis indicated that the computed activities were in excellent agreement with the experimentally observed values (r(2) = 0.91, rmsd = 0.225; predictive q(2) = 0.82, loormsd = 0.316). The generated models were further tested by use of an external prediction set of 15 molecules. The nonlinear ANN model has r(2) = 0.93 and root-mean-square errors of 0.282 compared with the experimentally measured activity of the test set. The stability test of the model with regard to data division was found to be positive, indicating that the generated model is predictive. The modeling study also reflected the important role of atomic distribution in the molecules, size, and steric structure of the molecules when they interact with the target, VMAT2. The developed models are expected to be useful in the rational design of new chemical entities as ligands of VMAT2 and for directing synthesis of new molecules in the future. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2975 / 2992
页数:18
相关论文
共 50 条
  • [1] Computational neural network analysis of the affinity of lobeline and tetrabenazine analogs for the vesicular monoamine transporter-2
    Zheng, Fang
    Zheng, Guangrong
    Deaciuc, A. Gabriela
    Zhan, Chang-Guo
    Dwoskin, Linda P.
    Crooks, Peter A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 844 - 844
  • [2] MEDI 269-Computational neural network analysis of the affinity of lobeline and tetrabenazine analogs for the vesicular monoamine transporter-2
    Cox, Christopher D.
    Coleman, Paul J.
    Fraley, Mark E.
    Garbaccio, Robert M.
    Breslin, Michael J.
    Whitman, David B.
    Schreier, John D.
    Hartman, George D.
    Torrent, Maricel
    Lobell, Rob
    Buser, Carolyn
    Tao, Weikang
    Huber, Hans
    Kohl, Nancy E.
    Yan, Youwei
    Kuo, Lawrence C.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 960 - 960
  • [3] Design, Synthesis and Interaction at the Vesicular Monoamine Transporter-2 of Lobeline Analogs: Potential Pharmacotherapies for the Treatment of Psychostimulant Abuse
    Crooks, Peter A.
    Zheng, Guangrong
    Vartak, Ashish P.
    Culver, John P.
    Zheng, Fang
    Horton, David B.
    Dwoskin, Linda P.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2011, 11 (09) : 1103 - 1127
  • [4] Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters
    Miller, DK
    Crooks, PA
    Zheng, GR
    Grinevich, VP
    Norrholm, SD
    Dwoskin, LP
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 310 (03): : 1035 - 1045
  • [5] Variants of the primate vesicular monoamine transporter-2
    Jassen, AK
    Brown, JM
    Panas, HN
    Miller, GM
    Xiao, DQ
    Madras, BK
    MOLECULAR BRAIN RESEARCH, 2005, 139 (02): : 251 - 257
  • [6] TRANSPORT OF HISTAMINE BY VESICULAR MONOAMINE TRANSPORTER-2
    MERICKEL, A
    EDWARDS, RH
    NEUROPHARMACOLOGY, 1995, 34 (11) : 1543 - 1547
  • [7] Kinetic analysis of developmental changes in vesicular monoamine transporter-2 function
    Volz, Trent J.
    Hanson, Glen R.
    Fleckenstein, Annette E.
    SYNAPSE, 2006, 60 (06) : 474 - 477
  • [8] Ephedrine Decreases Vesicular Monoamine Transporter-2 Function
    Ellis, Jonathan D.
    German, Christopher L.
    Birdsall, Elisabeth
    Hanson, Jarom E.
    Crosby, Marcus A.
    Rowley, Shane D.
    Sawada, Nicole A.
    West, Jeremiah N.
    Hanson, Glen R.
    Fleckenstein, Annette E.
    SYNAPSE, 2011, 65 (05) : 449 - 451
  • [9] Lobelane analogues as novel ligands for the vesicular monoamine transporter-2
    Zheng, GR
    Dwoskin, LP
    Deaciuc, AG
    Zhu, J
    Jones, MD
    Crooks, PA
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (12) : 3899 - 3909
  • [10] Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine
    Riddle, EL
    Topham, MK
    Haycock, JW
    Hanson, GR
    Fleckenstein, AE
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 449 (1-2) : 71 - 74